Receive our newsletter – data, insights and analysis delivered to you

Newsletter Weekly

Visit drugdevelopment-technology.com - www.drugdevelopment-technology.com. Weekly Round-Up

Industry News | Latest Research | White Papers | Latest Companies | Press Releases | Projects | Features

White Papers



Optimising Excipient Properties for ODT Formulation

Orally disintegrating tablets (ODTs), also known as orodispersible tablets, are unique dosage forms formulated to improve their in vivo disintegration and dissolution rates. It is a big challenge to ODT producers to achieve a minimum disintegration time while keeping formulation simple and robust. The required advances in pharmaceutical manufacturing occurred when excipient suppliers developed multi-functional types for direct compression. Roquette’s PEARLITOL®Flash, a combination of mannitol and starch, is a ready-to-use excipient for orodispersible tablets.

This article describes its application to formulation and how this delivers advantages like robustness and rapid disintegration time. PEARLITOL®Flash means problem-free ODT formulation.

 

Latest Companies



Abbott
– Biologics, High Potency and Finished Goods Contract Manufacturing Services

 

Press Releases



AVEVA to Exhibit at Drug Delivery Partnerships 2011
– Aveva


SHL’s Latest Autoinjector Featured in October 2010 Issue of OnDrugDelivery
– SHL


ISP Pharmaceuticals to Focus on Cryogenic Capabilities at Ohio Fine Chemicals Facility
– ISP


GE Healthcare Launches Amersham ECL Prime Chemiluminescent Western Blotting Reagent
– GE Healthcare


BENEO-Palatinit Presents its Multifunctional Excipient GalenIQ at AAPS 2010
– BENEO-Palatinit


Italvacuum to Attend India CHEM 2010
– Italvacuum


Endress+Hauser Announces Collaboration with SAP as a Core Partner of the Future Factory Initiative of the SAP Research Center in Dresden
– Endress+Hauser


Haselmeier to Attend 1-2-1 Sessions at Bio EUROPE
– Haselmeier

 

Projects



Penn Pharmaceutical Tredegar Plant, United Kingdom
Penn Pharmaceutical’s Tredegar plant is located in the Tafarnaubach Industrial Estate in Gwent, South Wales, UK. Launched in 1986, the Tredegar facility has been in operation for more than 20 years, and is FDA inspected and licensed by the MHRA.

Press Releases



Comparator Supplies – A Trial you Could do Without?
– Wellspring Clinical Services

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU